The New Healthcare (Second of a Series)

https://theleadleft.com/wp-content/uploads/2026/06/cropped-THE-LEAD-ICON.png
Content hub / Article / Commentary / The New Healthcare (Second of a Series)

We continue our special series on how the coronavirus is affecting the healthcare industry. At the heart of this pandemic is the doctor/patient relationship.

Much has been written about heroic efforts by first-responders in the early days of the crisis. Information gleaned on the front-line by those experiences has contributed greatly to a better understanding of how this virus spreads. The importance of washing hands, wearing masks and social distancing has only been solidified as a result.

We spoke recently to our own primary physician in a Zoom interview about his experience in a COVID-19 world.

“Thank goodness for telemedicine,” he told us, speaking from his home. “I can be very effective each day and have meaningful discussions with my patients. A lot of these now involve testing for the virus antibodies, which is easy and quick. You can get the results next day. And our staff can do all the blood work for general physicals.”

How will this pandemic change patient behavior, and your practice? “I think patients are acutely aware now of how these viruses spread,” he said, “and how to protect themselves from infection. We’re still a ways from a vaccine. Even then, there’s a lot of uncertainty. What’s clear is that we’re in for a long haul with this virus.”

Even before COVID, telemedicine was an already emerging dimension of healthcare. “There’s been real innovation in the space,” one healthcare lender told us. “In home healthcare, if a patient has a medical episode, the facility can automatically wheel up a device that takes the patient’s vitals. The doctor instantly sees the data and can address with medication. Remote medicine will certainly change and improve.”

It needs to, according to one top healthcare M&A partner. “The state of telehealth is just ok. It needs to go through another evaluation and evolution. It needs to change from just a reactive substitute for COVID, to something that’s better.

“There’s so much we don’t know,” he continued. “Prescriptions for antibiotics are higher for virtual than office visits. Why? To guard against bad on-line patient reviews? We don’t know. Just like teachers had to adapt this spring to distance learning, doctors have to modify the way they operate. Training needs to start in medical school.”

How will the doctor/patient relationship evolve? “It’s the same batch-processing of treatment and individuals that’s always been there. It’s very inefficient. You used to sit in the waiting room. Now you sit in your car. The old models don’t work in this environment. We need some residual barriers in place.

“Social distancing may be with us for good. Think about how travel changed after 9/11. We had to accept screening and security precautions. There needs to be the same massive shift in infrastructure and healthcare delivery systems. Telemedicine is just the 21st century version of housecalls. It’ll take time, but the paradigm has to change.”

Business development companies and the rise of balance sheet financing vehicles

Podcast

Business development companies and the rise of balance sheet financing vehicles

Fitch's Deb Murnin and Chelsea Richardson discuss the growing use of off-balance-sheet JVs and finance companies among BDCs, exploring the drivers, leverage impacts, portfolio risk profiles, and potential rating implications for Fitch-rated BDCs.
Listen
Private Debt Investor New York Forum

September 15-16, Hudson Yards, New York

Private Debt Investor New York Forum

Bringing together the investors, managers and advisers shaping the next phase of the market — 200+ allocators and $10.6 trillion of LP capital expected. Benchmark strategies, hear from leading LPs, and cut through market noise over two unmissable days.
Learn more
US Private Credit League Tables H1'26

Report

US Private Credit League Tables H1'26

The definitive rankings covering private credit activity in H1'26.
Download
PitchBook's Q2 2026 US PE Breakdown

Report

PitchBook's Q2 2026 US PE Breakdown

Software freezes and energy powers on as US PE deal value falls 38% in Q2 2026.
Download
Making sense of private credit defaults

Webinar

Making sense of private credit defaults

What does private credit default data really tell us? Join our exclusive webinar featuring experts from KBRA, Moody's, Fitch Ratings, and S&P Global to find out.
Register

Latest news

    PE exit activity

    Exit value fell to $102.6 billion in the second quarter—down 46.3% from the prior quarter and 7.4% YoY—while exit count dropped to 353, a 14.1% quarterly decline and a 5.4% rise against Q2 2025.

    Read More

    US BSL and MM CLO Performance Held Stable in July 2026

    In July 2026, portfolio credit quality in reinvesting Fitch-rated U.S. BSL CLOs remained broadly stable from June. Net portfolio losses held at 0.5%. The Fitch weighted average rating factor also held at 23.1. The Fitch weighted average recovery rate declined slightly by 0.1%, while the weighted average spread fell by 0.01%.

    Read More

    KBRA DLD Default Indices

    Read More